Intellia Therapeutics, Inc. (NTLA)
9.44
-0.17
(-1.77%)
USD |
NASDAQ |
Dec 08, 16:00
9.33
-0.11
(-1.17%)
Pre-Market: 08:54
Intellia Therapeutics Shareholders Equity (Quarterly): 748.42M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 505.82M |
| Regeneron Pharmaceuticals, Inc. | 30.96B |
| Beam Therapeutics, Inc. | 966.00M |
| Vertex Pharmaceuticals, Inc. | 17.32B |
| Pacific Biosciences of California, Inc. | 36.09M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 925.28M |
| Total Liabilities (Quarterly) | 176.85M |
| Debt to Equity Ratio | 0.1309 |
| Current Ratio | 6.209 |
| Net Debt Paydown Yield | 0.08% |